These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 11160618)

  • 41. Complex of an active mu-opioid receptor with a cyclic peptide agonist modeled from experimental constraints.
    Fowler CB; Pogozheva ID; Lomize AL; LeVine H; Mosberg HI
    Biochemistry; 2004 Dec; 43(50):15796-810. PubMed ID: 15595835
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modeling the similarity and divergence of dopamine D2-like receptors and identification of validated ligand-receptor complexes.
    Boeckler F; Lanig H; Gmeiner P
    J Med Chem; 2005 Feb; 48(3):694-709. PubMed ID: 15689154
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Investigation of the role of conserved serine residues in the long form of the rat D2 dopamine receptor using site-directed mutagenesis.
    Woodward R; Coley C; Daniell S; Naylor LH; Strange PG
    J Neurochem; 1996 Jan; 66(1):394-402. PubMed ID: 8522980
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The conserved methionine residue of the metzincins: a site-directed mutagenesis study.
    Hege T; Baumann U
    J Mol Biol; 2001 Nov; 314(2):181-6. PubMed ID: 11718552
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dopamine D2 receptor model explains binding affinity of neuroleptics: piquindone and its structure activity relationships.
    Teeter MM; Durand CJ
    Drug Des Discov; 1996 Apr; 13(3-4):49-62. PubMed ID: 8874043
    [No Abstract]   [Full Text] [Related]  

  • 46. Mapping the binding-site crevice of the dopamine D2 receptor by the substituted-cysteine accessibility method.
    Javitch JA; Fu D; Chen J; Karlin A
    Neuron; 1995 Apr; 14(4):825-31. PubMed ID: 7718244
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The second extracellular loop of the dopamine D2 receptor lines the binding-site crevice.
    Shi L; Javitch JA
    Proc Natl Acad Sci U S A; 2004 Jan; 101(2):440-5. PubMed ID: 14704269
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ligand selectivity of D2 dopamine receptors is modulated by changes in local dynamics produced by sodium binding.
    Ericksen SS; Cummings DF; Weinstein H; Schetz JA
    J Pharmacol Exp Ther; 2009 Jan; 328(1):40-54. PubMed ID: 18849360
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The first transmembrane segment of the dopamine D2 receptor: accessibility in the binding-site crevice and position in the transmembrane bundle.
    Shi L; Simpson MM; Ballesteros JA; Javitch JA
    Biochemistry; 2001 Oct; 40(41):12339-48. PubMed ID: 11591153
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The action of a negative allosteric modulator at the dopamine D
    Draper-Joyce CJ; Verma RK; Michino M; Shonberg J; Kopinathan A; Klein Herenbrink C; Scammells PJ; Capuano B; Abramyan AM; Thal DM; Javitch JA; Christopoulos A; Shi L; Lane JR
    Sci Rep; 2018 Jan; 8(1):1208. PubMed ID: 29352161
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 5-(N, N-Hexamethylene) amiloride is a GABA-A ρ1 receptor positive allosteric modulator.
    Snell HD; Gonzales EB
    Channels (Austin); 2016 Nov; 10(6):498-506. PubMed ID: 27367557
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Structural and functional characteristics of the dopamine D4 receptor.
    Van Tol HH
    Adv Pharmacol; 1998; 42():486-90. PubMed ID: 9327945
    [No Abstract]   [Full Text] [Related]  

  • 53. The role of a sodium ion binding site in the allosteric modulation of the A(2A) adenosine G protein-coupled receptor.
    Gutiérrez-de-Terán H; Massink A; Rodríguez D; Liu W; Han GW; Joseph JS; Katritch I; Heitman LH; Xia L; Ijzerman AP; Cherezov V; Katritch V; Stevens RC
    Structure; 2013 Dec; 21(12):2175-85. PubMed ID: 24210756
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dopamine D2 and D4 receptor heteromerization and its allosteric receptor-receptor interactions.
    Borroto-Escuela DO; Van Craenenbroeck K; Romero-Fernandez W; Guidolin D; Woods AS; Rivera A; Haegeman G; Agnati LF; Tarakanov AO; Fuxe K
    Biochem Biophys Res Commun; 2011 Jan; 404(4):928-34. PubMed ID: 21184734
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Determinants of ligand binding at the D2 dopamine receptor.
    Naylor L; Woodward R; Daniell S; Coley C; Strange P
    Biochem Soc Trans; 1995 Feb; 23(1):87-91. PubMed ID: 7758807
    [No Abstract]   [Full Text] [Related]  

  • 56. Mapping the binding-site crevice of the D2 receptor.
    Javitch JA
    Adv Pharmacol; 1998; 42():412-5. PubMed ID: 9327927
    [No Abstract]   [Full Text] [Related]  

  • 57. Modeling and mutational analysis of a putative sodium-binding pocket on the dopamine D2 receptor.
    Neve KA; Cumbay MG; Thompson KR; Yang R; Buck DC; Watts VJ; DuRand CJ; Teeter MM
    Mol Pharmacol; 2001 Aug; 60(2):373-81. PubMed ID: 11455025
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Models of G-protein coupled receptors revised for family-wide compliance with experimental data. A new sequence accommodation suggested for helix G.
    Röper D; Krüger P; Grötzinger J; Wollmer A; Strassburger W
    Recept Channels; 1995; 3(2):97-106. PubMed ID: 8581405
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Induced effects of sodium ions on dopaminergic G-protein coupled receptors.
    Selent J; Sanz F; Pastor M; De Fabritiis G
    PLoS Comput Biol; 2010 Aug; 6(8):. PubMed ID: 20711351
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CC chemokine receptor 2 is allosterically modulated by sodium ions and amiloride derivatives through a distinct sodium ion binding site.
    den Hollander LS; Zweemer AJM; Béquignon OJM; Hammerl DM; Bleijs BTM; Veenhuizen M; Lantsheer WJF; Chau B; van Westen GJP; IJzerman AP; Heitman LH
    Biochem Pharmacol; 2024 Aug; 229():116464. PubMed ID: 39111604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.